{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:17:49Z","timestamp":1792664269081,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["602300"],"award-info":[{"award-number":["602300"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017268","name":"Berlin Institute of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.bone.2018.12.002","type":"journal-article","created":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T10:49:48Z","timestamp":1544266188000},"page":"495-503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Sclerosing bone dysplasias with hallmarks of dysosteosclerosis in four patients carrying mutations in SLC29A3 and TCIRG1"],"prefix":"10.1016","volume":"120","author":[{"given":"Antonia","family":"Howaldt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheela","family":"Nampoothiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa-Marie","family":"Quell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse","family":"Ozden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Fischer-Zirnsak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Collet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"de Vernejoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Doneray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fclya","family":"Kayserili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4582-9838","authenticated-orcid":false,"given":"Uwe","family":"Kornak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2018.12.002_bb0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/cge.12448","article-title":"A founder mutation in the TCIRG1 gene causes osteopetrosis in the Ashkenazi Jewish population","volume":"88","author":"Anderson","year":"2015","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bone.2018.12.002_bb0010","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1074\/jbc.M414337200","article-title":"Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes","volume":"280","author":"Baldwin","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2018.12.002_bb0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S8756-3282(99)00244-6","article-title":"Type II autosomal dominant osteopetrosis (Albers-Schonberg disease): clinical and radiological manifestations in 42 patients","volume":"26","author":"Benichou","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.bone.2018.12.002_bb0020","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1093\/hmg\/dds326","article-title":"Whole-exome sequencing identifies mutations in the nucleoside transporter gene SLC29A3 in dysosteosclerosis, a form of osteopetrosis","volume":"21","author":"Campeau","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bone.2018.12.002_bb0025","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00439-002-0861-9","article-title":"Chloride channel 7 (CLCN7) gene mutations in intermediate autosomal recessive osteopetrosis","volume":"112","author":"Campos-Xavier","year":"2003","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bone.2018.12.002_bb0030","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ajmg.1320430304","article-title":"Skeletal dysplasia, intracerebral calcifications, optic atrophy, hearing impairment, and mental retardation: nosology of dysosteosclerosis","volume":"43","author":"Chitayat","year":"1992","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bone.2018.12.002_bb0035","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1093\/hmg\/10.25.2861","article-title":"Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene","volume":"10","author":"Cleiren","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bone.2018.12.002_bb0040","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1093\/nar\/gkp215","article-title":"Human Splicing Finder: an online bioinformatics tool to predict splicing signals","volume":"37","author":"Desmet","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bone.2018.12.002_bb0045","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1136\/jmg.39.8.603","article-title":"Dysosteosclerosis: a report of three new cases and evolution of the radiological findings","volume":"39","author":"Elcioglu","year":"2002","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bone.2018.12.002_bb0050","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000338886","article-title":"Identification of two novel mutations in SLC29A3 encoding an equilibrative nucleoside transporter (hENT3) in two distinct Syrian families with H syndrome: expression studies of SLC29A3 (hENT3) in human skin","volume":"224","author":"Farooq","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.bone.2018.12.002_bb0055","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/77131","article-title":"Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis","volume":"25","author":"Frattini","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2018.12.002_bb0060","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1359\/jbmr.2003.18.10.1740","article-title":"Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis","volume":"18","author":"Frattini","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.12.002_bb0065","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s10038-018-0447-6","article-title":"Dysosteosclerosis is also caused by TNFRSF11A mutation","volume":"63","author":"Guo","year":"2018","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.bone.2018.12.002_bb0070","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2214\/ajr.130.5.988","article-title":"Dysosteosclerosis","volume":"130","author":"Houston","year":"1978","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.bone.2018.12.002_bb0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.1213682","article-title":"Equilibrative nucleoside transporter 3 deficiency perturbs lysosome function and macrophage homeostasis","volume":"335","author":"Hsu","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.bone.2018.12.002_bb0080","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/bioinformatics\/bts462","article-title":"GeneTalk: an expert exchange platform for assessing rare sequence variants in personal genomes","volume":"28","author":"Kamphans","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bone.2018.12.002_bb0085","doi-asserted-by":"crossref","first-page":"28343","DOI":"10.1074\/jbc.M110.109199","article-title":"Human equilibrative nucleoside transporter-3 (hENT3) spectrum disorder mutations impair nucleoside transport, protein localization, and stability","volume":"285","author":"Kang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2018.12.002_bb0090","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/ajmg.a.35264","article-title":"Long-term survival in infantile malignant autosomal recessive osteopetrosis secondary to homozygous p.Arg526Gln mutation in CLCN7","volume":"158A","author":"Kantaputra","year":"2012","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bone.2018.12.002_bb0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(01)00206-9","article-title":"Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man","volume":"104","author":"Kornak","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.bone.2018.12.002_bb0100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1086\/377110","article-title":"Genetic disorders of the skeleton: a developmental approach","volume":"73","author":"Kornak","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bone.2018.12.002_bb0105","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/hmg\/9.13.2059","article-title":"Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis","volume":"9","author":"Kornak","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bone.2018.12.002_bb0110","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/ajmg.a.32182","article-title":"Clinical and radiologic findings in an adult male with dysosteosclerosis","volume":"146A","author":"Lemire","year":"2008","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bone.2018.12.002_bb0115","doi-asserted-by":"crossref","first-page":"14655","DOI":"10.1074\/jbc.274.21.14655","article-title":"Transmembrane topography of the 100-kDa a subunit (Vph1p) of the yeast vacuolar proton-translocating ATPase","volume":"274","author":"Leng","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2018.12.002_bb0120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00223-002-1087-5","article-title":"Type II benign osteopetrosis (Albers-Schonberg disease) caused by a novel mutation in CLCN7 presenting with unusual clinical manifestations","volume":"74","author":"Letizia","year":"2004","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2018.12.002_bb0125","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"key":"10.1016\/j.bone.2018.12.002_bb0130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ajhg.2008.09.013","article-title":"The H syndrome is caused by mutations in the nucleoside transporter hENT3","volume":"83","author":"Molho-Pessach","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bone.2018.12.002_bb0135","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.bone.2018.02.029","article-title":"Diagnostic strategies and genotype-phenotype correlation in a large Indian cohort of osteogenesis imperfecta","volume":"110","author":"Mrosk","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.bone.2018.12.002_bb0140","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/jbmr.2517","article-title":"Buried in the middle but guilty: intronic mutations in the TCIRG1 gene cause human autosomal recessive osteopetrosis","volume":"30","author":"Palagano","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.12.002_bb0145","doi-asserted-by":"crossref","first-page":"14775","DOI":"10.1074\/jbc.M117.787952","article-title":"Molecular determinants of acidic pH-dependent transport of human equilibrative nucleoside transporter 3","volume":"292","author":"Rahman","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.bone.2018.12.002_bb0150","article-title":"A novel missense mutation in the CLCN7 gene linked to benign autosomal dominant osteopetrosis: a case series","volume":"7","author":"Rashid","year":"2013","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.bone.2018.12.002_bb0155","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nmeth0810-575","article-title":"MutationTaster evaluates disease-causing potential of sequence alterations","volume":"7","author":"Schwarz","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bone.2018.12.002_bb0160","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/jbmr.2203","article-title":"As little as needed: the extraordinary case of a mild recessive osteopetrosis owing to a novel splicing hypomorphic mutation in the TCIRG1 gene","volume":"29","author":"Sobacchi","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.12.002_bb0165","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrendo.2013.137","article-title":"Osteopetrosis: genetics, treatment and new insights into osteoclast function","volume":"9","author":"Sobacchi","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bone.2018.12.002_bb0170","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1055\/s-0029-1228480","article-title":"Dysosteosclerosis\u2013a special form of generalized osteosclerosis","volume":"109","author":"Spranger","year":"1968","journal-title":"Fortschr Geb Rontgenstr Nuklearmed"},{"key":"10.1016\/j.bone.2018.12.002_bb0175","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bone.2018.12.002_bb0180","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/jbmr.131","article-title":"Dysosteosclerosis presents as an \u201costeoclast-poor\u201d form of osteopetrosis: comprehensive investigation of a 3-year-old girl and literature review","volume":"25","author":"Whyte","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.12.002_bb0185","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/aps.2017.108","article-title":"Novel mutations of TCIRG1 cause a malignant and mild phenotype of autosomal recessive osteopetrosis (ARO) in four Chinese families","volume":"38","author":"Zhang","year":"2017","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328218304447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328218304447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:41:34Z","timestamp":1757612494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328218304447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":37,"alternative-id":["S8756328218304447"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2018.12.002","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sclerosing bone dysplasias with hallmarks of dysosteosclerosis in four patients carrying mutations in SLC29A3 and TCIRG1","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2018.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}